Representatives from the Chinese side say they think it likely that Chinese President Xi Jinping will attend the G-20 meeting later this month. But in order to reach a trade...China Economyread more
Software engineers straight out of college often make six-figure salaries, not counting equity compensation.Technologyread more
Wall Street, though, is clamoring for a rate cut, with an 85% chance of a move in July and a 61% probability of three reductions by year's end.The Fedread more
A company spokesperson said the outage was the result of a "an internal technology issue" and was not security related.Retailread more
The flattening of the yield curve is exuding a bad omen for the stock market if history is any guide.Marketsread more
Using MIT's living wage calculator, CNBC Make It mapped out the minimum amount a single parent must earn to meet their basic needs without relying on outside help in every...Earnread more
Hong Kong Chief Executive Carrie Lam announced at a press conference on Saturday that a contentious bill to allow extraditions to mainland China has been put on hold.China Politicsread more
Stratolaunch, the world's largest airplane, which flew once, is up for sale, sources familiar told CNBC.Investing in Spaceread more
Transparency is key… or is it? With the first-ever non-transparent, actively managed exchange-traded fund receiving approval from the SEC, "ETF Edge" goes straight to the...ETF Edgeread more
Mired in a crisis over its best-selling 737 Max plane, Boeing could hand the spotlight over to its rival Airbus at the Paris Air Show.Airlinesread more
A new update to the Apple Watch called watchOS 6 will notify you if the environment you're in is too loud and could damage your hearing.Technologyread more
Check out the companies making headlines in midday trading Monday:
Beyond Meat— Shares of Beyond Meat popped 21%, on pace for its third best day ever. Earlier the stock hit $186.43 per share, an all-time high. The maker of plant-based meat substitutes has surged nearly 600% from its IPO price of $25 per share. The company soared a whopping 39% on Friday after it reported better-than-expected first-quarter earnings.
Retail stocks surged as the S&P retail ETF the XRT rose 0.8%. Two of the leaders of the XRT included GameStop, which jumped 8% after the gaming company announced it would buy back up to 12 million shares and Shutterfly, which rose 7% but closed up only 2%, after Reuters reported Apollo Global Management is in the lead to buy the company.
Shares of United Technologies fell 3% and Raytheon jumped less than 1% after the companies announced the previous day that they would merge into a defense and aerospace giant. The new company will be the second-largest aerospace and defense company in the U.S. by revenue, behind Boeing, as the companies estimate a combined annual sales of around $74 million. The new company will be called Raytheon Technologies.
Tableau Software— Shares of Tableau soared more than 33% after Salesforce.com said it will buy the big data firm for $15.3 billion. The all-stock deal is the biggest acquisition in Salesforce's history as it seeks to provide more data insights to its clients. Shares of Salesforce fell 5%.
Tilray— Shares of Tilray surged more than 11% after the Canadian weed company said it has reached a deal with private equity fund Privateer Holdings to sell the fund's stake gradually over the next two years. Privateer is a cannabis company backed by venture capitalist Peter Thiel, and it holds 75 million Tilray shares, or 77% of the outstanding shares.
Redfin— Shares of online real-estate company Redfin jumped more than 7% after Stephens upgraded the stock to overweight from underweight and raised its target price to $23 from $18. Stephens said the company is beginning to "lay the groundwork for more e-commerce type" offerings in the real estate space.
Analog Devices— Shares of Analog Devices rose more than 5% after Goldman Sachs upgraded the chipmaker to buy from sell. Goldman updated its 12-month price target to $114 for Analog. Since the bank put Analog on its sell list, the stock has risen 21%, leading Goldman to conclude its sell thesis "has not worked."
Spark Therapeutics— Shares of Spark Therapeutics tanked more than 8% on news that Swiss drugmaker Roche's $4.3 billion bid to buy the U.S. gene therapy specialist was delayed again due to U.S. and UK scrutiny. The U.S. Federal Trade Commission requested information and the UK Competition and Markets Authority opened an investigation into the two companies.
— CNBC's Yun Li contributed to this report.